nivolumab
bms
['nivolumab', 'nivo']
low dose nivolumab phase 3. #asco2022. 
Professor, Head and Neck-Medical Oncologist, Neuro-Medical Oncologist, Thoracic-Medical Oncologist,Researcher,Immunotherapy, Statistics and Phase 1/2/3 studies